Abstract
Proving that a new treatment is more effective than current treatment can be difficult for rare conditions. Data from small randomised trials could, however, be made more robust by taking other related research into account
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Data Interpretation, Statistical
-
Humans
-
Neoplasms / therapy*
-
Proportional Hazards Models
-
Randomized Controlled Trials as Topic / methods*
-
Rare Diseases / therapy*
-
Statistical Distributions